GSK sees positive results on asthma, COPD drug expected to succeed Advair
Links shared publicly online about this topic.
- 247total visits
GSK sees positive results on asthma, COPD drug expected to succeed Advair
GlaxoSmithKline reported strong results for drug candidate Relovair, which is being developed as a successor to blockbuster Advair. Read more about the study.
View full resource at medcitynews.com
Tags: Asthma, Asthma Medication, COPD, COPD Medication, Drug, Advair, GlaxoSmithKline
Most Recently Shared on June 2, 2011 at 8:55 pm By:
GSK sees positive results on asthma, COPD drug expected to succeed Advair http://bit.ly/m8w3MZ
Advertisement
